SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-24-042275
Filing Date
2024-04-05
Accepted
2024-04-05 16:15:03
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-05

Document Format Files

Seq Description Document Type Size
1 ARS vktx-2024-04-05-ars.pdf ARS 581726
  Complete submission text file 0000950170-24-042275.txt   792947
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37355 | Film No.: 24826686
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)